(Q44497833)

3 December 2017

Polyglutamine neurodegeneration: minding your Ps and Qs. (English)

1 reference

3 December 2017

1 reference

Henry Paulson

1

1 reference

PubMed ID

12835695

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

9

1 reference

3 December 2017

7

1 reference

3 December 2017

825-826

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0703-825

3 December 2017

0 references

cites work

Toxic proteins in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

SCA1 molecular genetics: a history of a 13 year collaboration against glutamines

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Identification of genes that modify ataxin-1-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Chaperoning brain degeneration

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

14-3-3zeta is an effector of tau protein phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNM0703-825

7 January 2021

Identifiers

DOI

10.1038/NM0703-825

1 reference

3 December 2017

1 reference

PubMed ID

12835695